Rituximab - Myositis
You are here : Home > Formulary Search > Rituximab - Myositis
I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.
Documentation
- No records returned.
PAD Profile
ChemicalSubstance :
Rituximab
Indication :
Myositis
Group Name :
Keywords :
Brand Names Include :
Truxima, Mabthera, Rixathon
Important Information :
Specialist centres only
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0
Other Indications
Below are listed other indications that Rituximab is used to treat.
- ANCA-positive vasculitis
- Any paediatric use
- Chronic inflammatory demyelinating polyneuropathy
- Connective tissue disease
- Graft versus Host Disease (GVHD)
- Immune thrombocytopenia
- Immunoglobulin G4 related disease
- Refractory vasculitis
- Rheumatoid arthritis
- Sjogren's syndrome
- Systemic Lupus Erythematosus
Other Drugs
Below are listed other drugs that are used to treat Myositis.
- No records returned.
Committee Recommendations (1)
16 Apr 18 -
Not Set
This drug / device falls under the responsibility of NHS England Specialised Commissioning and should therefore not be prescribed in Primary Care.
Treatment should remain with the specialist (RED) hospital only drug.
GPs should ensure that patient medication records include any medicine for which prescribing remains the responsibility of secondary or tertiary care. This will ensure that GP records, which are accessed by other healthcare providers, are a true and accurate reflection of the patient’s medication.
Treatment should remain with the specialist (RED) hospital only drug.
GPs should ensure that patient medication records include any medicine for which prescribing remains the responsibility of secondary or tertiary care. This will ensure that GP records, which are accessed by other healthcare providers, are a true and accurate reflection of the patient’s medication.